Diagnostic accuracy of multiplex respiratory pathogen panels for influenza or respiratory syncytial virus infections: systematic review and meta-analysis

被引:4
|
作者
Jullien, Sophie [1 ]
Fitzgerald, Felicity [2 ]
Keddie, Suzanne [3 ]
Baerenbold, Oliver [2 ]
Bassat, Quique [1 ,4 ,5 ,6 ,7 ]
Bradley, John [3 ]
Falconer, Jane [3 ]
Fink, Colin [8 ,9 ]
Keogh, Ruth [3 ]
Hopkins, Heidi [3 ]
Voice, Marie [8 ]
机构
[1] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Carrer Rossello 132, Barcelona 08036, Spain
[2] Imperial Coll London, London, England
[3] London Sch Hyg & Trop Med, London, England
[4] Ctr Invest Saude Manh CISM, Maputo, Mozambique
[5] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain
[6] Univ Barcelona, Pediat Dept, Hosp St Joan Deu, Barcelona, Spain
[7] Consorcio Invest Biorned Red Epidemiol & Salud Pu, Madrid, Spain
[8] Univ Warwick, Micropathol Ltd, Sci Pk, Coventry, W Midlands, England
[9] Univ Warwick, Dept Life Sci, Coventry, W Midlands, England
基金
英国医学研究理事会;
关键词
Respiratory syncytial virus; Influenza virus; Diagnosis; Molecular diagnostics; Respiratory infection; CLINICAL-EVALUATION; SEASONAL INFLUENZA; YOUNG-CHILDREN; BURDEN; PCR; MORTALITY; ASSAY; BIAS;
D O I
10.1186/s12879-022-07766-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Respiratory syncytial virus (RSV) and influenza viruses are important global causes of morbidity and mortality. We evaluated the diagnostic accuracy of the Luminex NxTAG respiratory pathogen panels (RPPs)(TM) (index) against other RPPs (comparator) for detection of RSV and influenza viruses. Studies comparing human clinical respiratory samples tested with the index and at least one comparator test were included. A random-effect latent class meta-analysis was performed to assess the specificity and sensitivity of the index test for RSV and influenza. Risk of bias was assessed using the QUADAS-2 tool and certainty of evidence using GRADE. Ten studies were included. For RSV, predicted sensitivity was 99% (95% credible interval [CrI] 96-100%) and specificity 100% (95% CrI 98-100%). For influenza A and B, predicted sensitivity was 97% (95% CrI 89-100) and 98% (95% CrI 88-100) respectively; specificity 100% (95% CrI 99-100) and 100% (95% CrI 99-100), respectively. Evidence was low certainty. Although index sensitivity and specificity were excellent, comparators' performance varied. Further research with clear patient recruitment strategies could ascertain performance across different populations. Protocol Registration: Prospero CRD42021272062.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Effects of cinnamaldehyde on anti-respiratory syncytial virus A protocol of systematic review and meta-analysis
    Feng, Lan
    Li, Jing
    Yu, Hai-Bo
    Xue, Qing
    Dai, Li-Juan
    MEDICINE, 2020, 99 (20)
  • [32] Respiratory syncytial virus disease burden in children and adults from Latin America: a systematic review and meta-analysis
    Ciapponi, Agustin
    Palermo, Maria Carolina
    Sandoval, Maria Macarena
    Baumeister, Elsa
    Ruvinsky, Silvina
    Ulloa-Gutierrez, Rolando
    Stegelmann, Katharina
    Ruesjas, Sofia Ardiles
    Cantos, Joaquin
    Larotta, Jorge
    de Almeida, Rodrigo Sini
    Bardach, Ariel
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [33] Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis
    Sanchez-Solis, M.
    Gartner, S.
    Bosch-Gimenez, V.
    Garcia-Marcos, L.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (03) : 298 - 303
  • [34] Systematic literature review of the signs and symptoms of respiratory syncytial virus
    Colosia, Ann
    Costello, Jessica
    McQuarrie, Kelly
    Kato, Kelly
    Bertzos, Kristi
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (02)
  • [35] Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis
    Sofia Tejada
    Raquel Martinez-Reviejo
    Hanife N. Karakoc
    Yolanda Peña-López
    Oriol Manuel
    Jordi Rello
    Advances in Therapy, 2022, 39 : 4037 - 4051
  • [36] Global distribution of respiratory syncytial virus A and B infections: a systematic review
    Cantu-Flores, Karla
    Rivera-Alfaro, Gerardo
    Carlos Munoz-Escalante, Juan
    Noyola, Daniel E.
    PATHOGENS AND GLOBAL HEALTH, 2022, 116 (07) : 398 - 409
  • [37] Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis
    Sun, Mingyao
    Lai, Honghao
    Na, Feiyang
    Li, Sheng
    Qiu, Xia
    Tian, Jinhui
    Zhang, Zhigang
    Ge, Long
    JAMA NETWORK OPEN, 2023, 6 (02) : E230023
  • [38] Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis
    Tejada, Sofia
    Martinez-Reviejo, Raquel
    Karakoc, Hanife N.
    Pena-Lopez, Yolanda
    Manuel, Oriol
    Rello, Jordi
    ADVANCES IN THERAPY, 2022, 39 (09) : 4037 - 4051
  • [39] Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
    Grace, Mei
    Colosia, Ann
    Wolowacz, Sorrel
    Panozzo, Catherine
    Ghaswalla, Parinaz
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 742 - 759
  • [40] Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
    Pang, Yi
    Lu, Haishan
    Cao, Demin
    Zhu, Xiaoying
    Long, Qinqin
    Tian, Fengqin
    Long, Xidai
    Li, Yulei
    BMC PUBLIC HEALTH, 2024, 24 (01)